Ahmet Müçteba YILDIRIM
MD
Orthopaedics
Istanbul Medeniyet University, Orthopedics and Traumatology Department
EDUCATION: • Medical Faculty: Hacettepe University, Faculty of Medicine (2011 – 2017) • Residency: Istanbul University, Istanbul Faculty of Medicine, Orthopedics and Traumatology (2018 – 2023) WORKİNG EXPERIENCE • General Practitioner: Çorum Dodurga District Hospital (2017 – 2018) • Research Assistant (MD): Istanbul University, Istanbul Faculty of Medicine (2018 – 2023) • Orthopedic Specialist: Şanlıurfa Akçakale State Hospital (2023 – 2025) • Assistant Professor: Istanbul Medeniyet University (2025 – Present) WORKİNG EXPERIENCE • Assistant Professor: Istanbul Medeniyet University (2025 – Present) • Orthopedic Specialist: Şanlıurfa Akçakale State Hospital (2023 – 2025) CLINICAL INTERESTS • Orthopedic Oncology and Bone Tumors • Pediatric Orthopedic Surgery • Trauma and Reconstructive Surgery Istanbul Medeniyet University, Orthopedics and Traumatology Department ahmetmuctebaitf@gmail.com
Special Interests
Published Articles
Giant Cell Tumor (GCT)
GCBT is an aggressive benign bone tumour, classified as intermediate (locally aggressive) in the 2020 WHO classification. Accounts for 5–10% of all primary bone tumours.
March 31, 2026
Enchondroma
Overview • Enchondroma is a benign hyaline cartilage tumor, accounting for 20-25% of benign bone tumors. • It arises from residual cartilage cells that fail to undergo necrosis after physeal growth. • Can be solitary or multiple (Ollier’s disease, Maffucci syndrome).
March 30, 2026
Staging Systems (Enneking, AJCC)
March 30, 2026